3 Exciting Biotechs Under $30: Novocure Is Revolutionizing Brain Cancer Treatment
Novocure (NASDAQ: NVCR) is the company behind TTFields, a revolutionary new and nontoxic treatment for glioblastoma that uses low-intensity, alternating electrical fields to impede cancerous cell division, and kill cancer cells.
In this Industry Focus: Healthcare segment, Motley Fool analyst Kristine Harjes and contributor Todd Campbell explain how the treatment works, why it's so incredibly exciting for patients and doctors, how much Novocure is making on the treatment already, how it might expand its addressable market in the next few years, and more.
A full transcript follows the video.
Source: Fool.com
